-DOCSTART- -X- O
Recently -X- _ O
, -X- _ O
the -X- _ O
risk -X- _ O
of -X- _ O
viral -X- _ O
infection -X- _ O
has -X- _ O
dramatically -X- _ O
increased -X- _ O
owing -X- _ O
to -X- _ O
changes -X- _ O
in -X- _ O
human -X- _ O
ecology -X- _ O
such -X- _ O
as -X- _ O
global -X- _ O
warming -X- _ O
and -X- _ O
an -X- _ O
increased -X- _ O
geographical -X- _ O
movement -X- _ O
of -X- _ O
people -X- _ O
and -X- _ O
goods. -X- _ O
Howev- -X- _ O
er -X- _ O
, -X- _ O
the -X- _ O
efficacy -X- _ O
of -X- _ O
vaccines -X- _ O
and -X- _ O
remedies -X- _ O
for -X- _ O
infectious -X- _ O
diseases -X- _ O
is -X- _ O
limited -X- _ O
by -X- _ O
the -X- _ O
high -X- _ O
mutation -X- _ O
rates -X- _ O
of -X- _ O
viruses -X- _ O
, -X- _ O
especially -X- _ O
, -X- _ O
RNA -X- _ O
viruses. -X- _ O
Here -X- _ O
, -X- _ O
we -X- _ O
comprehensively -X- _ O
review -X- _ O
the -X- _ O
effectiveness -X- _ O
of -X- _ O
several -X- _ O
probiot-ics -X- _ B-Intervention
and -X- _ I-Intervention
paraprobiotics -X- _ I-Intervention
( -X- _ I-Intervention
sterilized -X- _ I-Intervention
probiotics -X- _ I-Intervention
) -X- _ I-Intervention
for -X- _ O
the -X- _ O
prevention -X- _ O
or -X- _ O
treatment -X- _ O
of -X- _ O
virally-induced -X- _ B-Patient
infectious -X- _ I-Patient
diseases. -X- _ I-Patient
We -X- _ O
discuss -X- _ O
the -X- _ O
unique -X- _ O
roles -X- _ O
of -X- _ O
these -X- _ O
agents -X- _ O
in -X- _ O
modulating -X- _ O
the -X- _ O
cross-talk -X- _ O
between -X- _ O
commensal -X- _ O
bacteria -X- _ O
and -X- _ O
the -X- _ O
mucosal -X- _ O
immune -X- _ O
system. -X- _ O
In -X- _ O
addition -X- _ O
, -X- _ O
we -X- _ O
provide -X- _ O
an -X- _ O
overview -X- _ O
of -X- _ O
the -X- _ O
unique -X- _ O
mechanism -X- _ O
by -X- _ O
which -X- _ O
viruses -X- _ B-Outcome
are -X- _ I-Outcome
eliminated -X- _ I-Outcome
through -X- _ I-Outcome
the -X- _ I-Outcome
stimulation -X- _ I-Outcome
of -X- _ I-Outcome
type -X- _ I-Outcome
1 -X- _ I-Outcome
interferon -X- _ I-Outcome
production -X- _ I-Outcome
by -X- _ I-Outcome
probiotics -X- _ I-Outcome
and -X- _ I-Outcome
paraprobiotics -X- _ I-Outcome
via -X- _ I-Outcome
the -X- _ I-Outcome
activation -X- _ I-Outcome
of -X- _ I-Outcome
dendritic -X- _ I-Outcome
cells. -X- _ I-Outcome
Although -X- _ O
further -X- _ O
detailed -X- _ O
research -X- _ O
is -X- _ O
necessary -X- _ O
in -X- _ O
the -X- _ O
future -X- _ O
, -X- _ O
probiotics -X- _ B-Intervention
and -X- _ I-Intervention
/ -X- _ I-Intervention
or -X- _ I-Intervention
paraprobiotics -X- _ I-Intervention
are -X- _ O
expected -X- _ O
to -X- _ O
be -X- _ O
among -X- _ O
the -X- _ O
rational -X- _ O
adjunctive -X- _ O
options -X- _ O
for -X- _ O
the -X- _ O
treatment -X- _ O
of -X- _ O
various -X- _ O
viral -X- _ O
diseases -X- _ O
. -X- _ O

